Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Indiana University School of Medicine Eli Lilly and Company |
---|---|
Information provided by: | Indiana University |
ClinicalTrials.gov Identifier: | NCT00532480 |
The purpose of this study is to find out what parts of the brain have increased or decreased activity when people are depressed and how antidepressant medicine changes this activity in depressed patients. The genetic samples collected are to look at variation in a gene (serotonin transporter gene), which affects the functioning of the chemical serotonin in the brain
Condition | Intervention | Phase |
---|---|---|
Major Depression |
Drug: Duloxetine |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment |
Official Title: | Duloxetine Effects on Brain fMRI Response to Emotionally Valenced Pictures in the Treatment of Patients With Major Depression |
Estimated Enrollment: | 15 |
Study Start Date: | September 2007 |
Estimated Study Completion Date: | January 2011 |
Estimated Primary Completion Date: | January 2011 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1 |
Drug: Duloxetine
60 mg capsules
|
This study will measure the activity in different parts of the brain, while the patients are seeing some pictures, using Magnetic Resonance Imaging (MRI) scan. For this study three MRI scans will be conducted. One before the patient begins on any medication, one during the study after 3 weeks of treatment and one after six more weeks of treatment with a standard antidepressant called duloxetine.
Ages Eligible for Study: | 18 Years to 60 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria for Depressed Patients:
Able to be managed as outpatients for initial assessment and during treatment as ascertained by the following:
Exclusion criteria for patients:
Contact: Abi French, MS | 317-274-0318 | abdfrenc@iupui.edu |
Contact: Amit Anand, MD | 317-274-7422 |
United States, Indiana | |
Indiana University Adult Psychiatric Clinic | Recruiting |
Indianapolis, Indiana, United States, 46202 | |
Contact: Abi French, MS 317-274-0318 abdfrenc@iupui.edu |
Principal Investigator: | Amit Anand, MD | Indiana University Schoole of Medicine |
Responsible Party: | Indiana University School of Medicine, Department of Psychiatry ( Amit Anand ) |
Study ID Numbers: | 0607-22 |
Study First Received: | September 18, 2007 |
Last Updated: | July 15, 2008 |
ClinicalTrials.gov Identifier: | NCT00532480 |
Health Authority: | United States: Institutional Review Board |
Depression Duloxetine fMRI pictures |
Dopamine Depression Mental Disorders Mood Disorders Depressive Disorder, Major |
Depressive Disorder Serotonin Duloxetine Behavioral Symptoms |
Dopamine Uptake Inhibitors Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Adrenergic Agents Adrenergic Uptake Inhibitors Physiological Effects of Drugs Psychotropic Drugs |
Serotonin Uptake Inhibitors Pharmacologic Actions Serotonin Agents Therapeutic Uses Dopamine Agents Central Nervous System Agents Antidepressive Agents |